Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anti-TCR-alphabeta monoclonal antibody H57-597

Drug Profile

Anti-TCR-alphabeta monoclonal antibody H57-597

Alternative Names: Anti-alphabeta monoclonal antibody H57; Anti-T-cell-receptor-alphabeta monoclonal antibody H57-597; anti-T-cell-receptor-αβ monoclonal antibody H57-597; anti-αβ monoclonal antibody H57; H57; H57-597

Latest Information Update: 10 Aug 1998

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Unknown
  • Developer Nissui Pharmaceutical; Nonindustrial source
  • Class Monoclonal antibodies
  • Mechanism of Action T-cell receptor antigen alpha-beta antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Graft-versus-host disease; Transplant rejection

Most Recent Events

  • 10 Aug 1998 No-Development-Reported for Graft-versus-host disease in Japan (Unknown route)
  • 10 Aug 1998 No-Development-Reported for Transplant rejection in Japan (Unknown route)
  • 10 Aug 1998 No-Development-Reported for Transplant rejection in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top